Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysis-Reference-Cited by-同舟云学术

Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysis

Published:2020-06-24 Issue:8 Volume:36 Page:1325-1332
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Asselah Tarik¹,Zeuzem Stefan²,Reau Nancy³,Hwang Peggy⁴,Long Jianmin⁴,Talwani Rohit⁴,Robertson Michael N.⁴,Haber Barbara A.⁴

Affiliation:

1. Department of Hepatology, INSERM UMR1149, University Paris Diderot, Hôpital Beaujon, Clichy, France;

2. Department of Medicine, Goethe University Hospital, Frankfurt, Germany;

3. Department of Hepatology, Rush University Medical Center, Chicago, IL, USA;

4. Department of Infectious Disease, Merck & Co. Inc., Kenilworth, NJ, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1775075

Reference39 articles.

1. Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014

2. Center for Disease Control and Prevention. New hepatitis C infections nearly tripled over five years [press release] [Internet]. Centers for Disease Control and Prevention web site; 2017 [cited 2020 Jan 14]. Available from: https://www.cdc.gov/nchhstp/newsroom/2017/Hepatitis-Surveillance-Press-Release.html

3. European Centre for Disease Prevention and Control. Hepatitis C – Annual Epidemiologic Report for 2015. 2017 [cited 2020 Jan 14]. Available from: https://www.ecdc.europa.eu/en/publications-data/hepatitis-c-annual-epidemiological-report-2015

4. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

5. Increased Risk for Mother-to-Infant Transmission of Hepatitis C Virus Among Medicaid Recipients ― Wisconsin, 2011–2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection;Frontiers in Pharmacology;2021-09-09

2. In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain;European Journal of Pharmacology;2021-01

3. Elbasvir/grazoprevir;Reactions Weekly;2020-09